Ekso Bionics Holdings Inc. priced its public offering of common stock and warrants to raise about $10 million in gross proceeds.

The Richmond, Calif.-based healthcare equipment company is selling 6,666,667 common shares and warrants to buy 6,666,667 common shares at $1.50 per common share and accompanying warrant. The five-year warrants are exercisable at $2 per share upon issuance.

Cantor Fitzgerald & Co. is acting as lead book-running manager for the offer, while SunTrust Robinson Humphrey Inc. is acting as joint book-running manager.

Ekso Bionics' products range from technologies supporting mobility of patients with paralysis to solutions enhancing human capabilities for industrial use.